Cargando…
The Manufacture of Xeno- and Feeder-Free Clinical-Grade Human Embryonic Stem Cell Lines: First Step for Cell Therapy
Human embryonic stem cells (hESCs) are increasingly used in clinical trials as they can change the outcome of treatment for many human diseases. They are used as a starting material for further differentiation into specific cell types and to achieve the desirable result of the cell therapy; thus, th...
Autores principales: | Souralova, Tereza, Rehakova, Daniela, Jeseta, Michal, Tesarova, Lenka, Beranek, Jindrich, Ventruba, Pavel, Hampl, Ales, Koutna, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604167/ https://www.ncbi.nlm.nih.gov/pubmed/36293356 http://dx.doi.org/10.3390/ijms232012500 |
Ejemplares similares
-
Truncated vitronectin with E-cadherin enables the xeno-free derivation of human embryonic stem cells
por: Souralova, Tereza, et al.
Publicado: (2023) -
Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy
por: Rehakova, Daniela, et al.
Publicado: (2020) -
DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing
por: Simara, Pavel, et al.
Publicado: (2017) -
Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells
por: Simara, Pavel, et al.
Publicado: (2018) -
Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium
por: Farkas, Simon, et al.
Publicado: (2020)